Investor Resources

Quick Explore

icon-pdf
Amalgamation of a wholly owned step down subsidiary, Cipla Pharma Lanka (Private) Limited with Company’s another wholly owned step-down subsidiary, Breathe Free Lanka (Private) Limited
22nd Jul 2020
icon-pdf
Update on Cipla and Amgen reach a settlement on pending litigation involving generic cinacalcet hydrochloride tablets (30mg, 60mg and 90mg)
20th Jul 2020
icon-pdf
Allotment of 37,102 equity shares under ESOS
16th Jul 2020
icon-pdf
Notice of Board Meeting – Newspaper Publication
16th Jul 2020
icon-pdf
Notice of Board Meeting – August 2020
15th Jul 2020
icon-pdf
Press release - Cipla receives final approval for generic version of Shire’s Firazyr® (Icatibant Injectable Pre-Filled Syringe 30mg/3mL)
14th Jul 2020
icon-pdf
Update on the Definitive Agreement entered between Cipla Technologies LLC and Pulmatrix for Development and Commercialization of Pulmazole
13th Jul 2020
icon-pdf
Record of Investor Meetings – June ’20
30th Jun 2020
icon-pdf
Schedule of Analyst / Institutional Investor Meetings
29th Jun 2020
icon-pdf
Press Release – Cipla and Boehringer Ingelheim forge partnership to co-market three oral anti-diabetic drugs
29th Jun 2020
 
BSE and NSE Quotes by TradingView

The displayed data is not in real time and may have streaming delays.